Adenomyosis
Also known as: Uterine adenomyosis, Adenomyosis uteri, Internal endometriosis (historical term)
Adenomyosis is characterized by the ectopic presence of endometrial tissue within the uterine myometrium, frequently presenting with dysmenorrhoea, menorrhagia, chronic pelvic pain, and subfertility. Conventional clinical management necessitates gynaecological evaluation for definitive diagnosis, screening for iron-deficiency anaemia, and symptomatic control via pharmacological or surgical intervention. Within this framework, Traditional Chinese Medicine (TCM) serves solely as adjunctive support. Current clinical evidence is limited and preliminary: a pilot trial involving 66 participants investigated an unspecified herbal combination in conjunction with High-Intensity Focused Ultrasound (HIFU) rather than the formulas detailed herein [2]. A retrospective study concerning chronic pelvic pain is insufficient to determine the specific efficacy of acupuncture for adenomyosis [1]. Additionally, the cited dysmenorrhoea publication represents a protocol for guideline development rather than finalised clinical recommendations [3], and the endometriosis review pertains to a distinct pathology [4]. The cited data do not establish TCM as a means to reverse the disease process, enhance fertility, or validate the efficacy of the proposed acupuncture point prescriptions.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Maintain a menstrual diary to document pain intensity, volume of haemorrhage, presence of clots, pharmacological interventions, and functional impairment.
- •Prioritise low-impact physical activity, such as walking or stretching, and ensure adequate rest; avoid strenuous exertion during acute pain episodes.
- •Maintain a regular diet incorporating iron-rich foods, noting that dietary intake is frequently insufficient to resolve clinical iron deficiency.
- •Consult with a gynaecologist regarding contraception, reproductive objectives, and treatment preferences prior to the initiation of herbal medicine or adjunctive procedures.
Cautions & Contraindications
- •The supplied abstracts do not establish pregnancy or fertility-treatment safety. Avoid blood-moving herbal prescriptions during pregnancy and obtain specialist review before any herbal treatment when conception is possible; the HIFU adjunct trial cannot establish safety for the formulas listed here [2].[]
- •Defer acupuncture in haemodynamic instability, uncontrolled bleeding or suspected acute pelvic pathology. Assess anticoagulation, bleeding disorders and local infection before needling. These are general precautions, not safety rules validated by the retrospective study [1].[]
- •Do not extrapolate normal safety indicators in a small pilot trial to all herbs, products or patients. Reconcile medicines, verify ingredients and coordinate herbal cessation or continuation around surgery or HIFU with the procedural team [2].[]
When to reassess or seek care again
Review after 2–4 weeks and again after two menstrual cycles. Record 0–10 pain scores, bleeding diary or PBAC, analgesic use, sleep and days of restricted activity; follow medically indicated blood count and iron studies. Stop or revise adjunctive care if symptoms worsen, adverse effects occur or there is no meaningful patient-defined improvement after two cycles. Persistent heavy bleeding, suspected anaemia or fertility concerns warrant medical or gynaecological review without waiting for this interval.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2026
- International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2026
- JMIR research protocols · 2026
- Drug design, development and therapy · 2026
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
